The comparative clinical efficacy of intravenous insulin regular, dexamethasone and flunixin meglumine on ovine experimental endotoxemia

Document Type : Research Paper

Authors

Department of Clinical Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran

Abstract

The lack of an effective treatment for endotoxemia causes high mortality rates in affected animals. Forty clinically healthy 1-year old Iranian fat-tailed ewes were assigned randomly into 8 experimental equal (n = 5) groups, comprising Insln 1.5, Insln 3, Insln 6, Insln 9, Insln 20, Dexa, Flnx and Control. Lipopolysaccharide from E. coli serotype O55:B5 was used to induce endotoxemia in ewes at 20 µg/kg as bolus intravenous administration. All forty ewes were evaluated clinically before and 1, 2, 3, 4, 5, 6 and 24 h after LPS injection. Clinical parameters monitored during experiments included rectal temperature, heart and respiratory rates, mucous membrane color, capillary refill time, appetite and fecal consistency. Insulin regular, flunixine meglumine and dexamethasone were used at 180 min after LPS injection along with the fluid over 60 min. Insulin regular was infused at 1.5, 3, 6, 9 and 20 IU/kg in Insln 1.5, Insln 3, Insln 6, Insln 9 and Insln 20 groups, respectively. Flunixin meglumine and dexamethasone were used at 2.2 mg/kg and 1 mg/kg intravenously in Flnx and Dexa groups, respectively. In Insln 3 group, at 5th and 6th hours, the heart rate was significantly lower than other experimental groups. Respiratory rate of all studied animals at 5th and 6th hours in Insln 3, Flnx and Dexa were statistically similar together and lower than other groups, significantly. In conclusion, the anti endotoxic effects of insulin regular at 3 IU/kg were statistically similar to dexamethasone (1 mg/kg) and flunixin meglumine (2.2 mg/kg).

Keywords


References
Brigham, KL. & Meyrick, B. (1986). Endotoxin and lung injury. Am. Rev. Respir. Dis. 133, 913-927.
 
 Centanni, E. (1984). Untersuchungen über das Infections-fieber. Dtsch. tierärztl. Wschr. 20, 148-179.
 
Chalmeh, A., Badiei, K., Pourjafar, M. & Nazifi, S. (2013a). Acute phase response in experimentally Escherichia coli serotype O55:B5 induced endotoxemia and its comparative treatment with dexamethasone and flunixin meglumine in Iranian fat-tailed sheep. Vet. Arhiv. 83, 301-312.
 
Chalmeh, A., Badiei, K., Pourjafar, M. & Nazifi, S. (2013b). Anti-inflammatory effects of insulin regular and flunixin meglumine on endotoxemia experimentally induced by Escherichia coli serotype O55 :B5 in an ovine model. Inflamm. Res. 62, 61-67
 
Chalmeh, A., Badiei, K., Pourjafar, M. & Nazifi, S. (2013c). Modulation of inflammatory responses following insulin therapy in experimentally bolus intravenous Escherichia coli lipopolysaccharide sterotype O55:B5 induced endotoxemia in Iranian fat-tailed sheep. Small Rumin. Res. 113, 283-289.
 
Dandona, P., Mohanty, P., Chaudhuri, A., Garg, R. & Aljada, A. (2005). Insulin infusion in acute illness. J. Clin. Invest. 115, 2069–2072.
 
Danek, J. & Żurek, U. (2014). Changes in domestic animals after endotoxin administration-a review. Ann. Anim. Sci. 14, 479–489.
 
Frost, RA., Lang, CH. & Gelato, MC. (1997). Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 138, 4153–4159.
 
Hajimohammadi, A., Badiei, K., Kheibari, P., Pourjafar, M. & Chalmeh, A. (2018). Effects of polymyxin B on clinical signs, serum TNF-α, haptoglobin and plasma lactate concentrations in experimental endotoxaemia in sheep. J. Vet. Res. 62, 79-85.
 
Heidari, S., Badiei, K., Pourjafar, M., Chalmeh, A. & Rahmani Shahraki, A. (2016). Comparative therapeutic effects of tyloxapol, betamethasone and flunixin meglumine on clinical parameters following experimental endotoxemia induction in sheep. The 1st International Congress of Large Animal Internal Medicine, Shiraz, Iran.
 
Jaffer, U., Wade, RG. & Gourlay, T. (2010). Cytokines in the systemic inflammatory response syndrome: a review HSR Proc. Intensive Care Cardiovasc. Anesth. 2, 161–175.
 
Jeschke, M.G., Einspanier, R., Klein, D. & Jauch, KW. (2002). Insulin attenuates the systemic inflammatory response to thermal trauma. Mol. Med. 8, 443–450.
 
Jeschke, M.G., Klein, D., Bolder, U. & Einspanier, R. (2004). Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145, 4084-4093.
 
Iwasaki, Y., Nishiyama, M., Taguchi, T., Asai, M., Yoshida, M., Kambayashi, M., Terada, Y. & Hashimoto, K. (2009). Insulin exhibits short term anti-inflammatory but long-term proinflammatory effects in vitro. Mol. Cell Endocrinol. 298, 25–32.
 
Kox, M., Ramakers, BP., Pompe, J.C., Van Der Hoeven, JG., Hoedemaekers, CW. & Pickkers, P. (2011). Interplay between the acute inflammatory response and heart rate variability in healthy human volunteers. Shock. 36, 115-120.
 
Leffler, M., Hrach, T., Stuerzl, M., Horch, RE., Herndon, DN. & Jeschke, MG. (2007). Insulin attenuates apoptosis and exerts anti-inflammatory effects in endotoxemic human macrophages. J. Surg. Res. 143, 398–406.
 
Lohuis, JACM., Verheijden, JHM., Burvenich, C. & Miert, ASJPAM. (1988). Pathophysiological effects of endotoxins in ruminants. 1. Changes in body temperature and reticulo-rumen motility, and the effect of repeated administration. 2. Metabolic aspects. Vet. Q. 10, 109-125.
 
Mokra, D., Tonhajzerova, I., Pistekova, H., Visnovcova, Z., Mokry, J., Drgova, A., Repcakova, M. & Calkovska, A. (2013). Short-term cardiovascular effects of selective phosphodiesterase 3 inhibitor olprinone versus non-selective phosphodiesterase inhibitor aminophylline in a meconium-induced acute lung injury. J. Physiol. Pharmacol. 64, 751-759.
 
Moore, JN. & Barton, MH. (2003). Treatment of endotoxemia. Vet. Clin. North. Am. Equine. Pract. 19, 681–695.
 
Niehof, M., Streetz, K., Rakemann, T., Bischoff, SC., Manns, M.P., Horn, F. & Trautwein, C. (2001). Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3. J. Biol. Chem. 276, 9016–9027.
 
Radostits, O.M., Gay, C.C., Hinchcliff, K.W. & Constable, P.D. (2007). Toxemia and endotoxemia. In: Veterinary medicine: a text book of the diseases of cattle, horses, sheep, pigs and goats. Elsevier, Amsterdam. 10th ed. PP: 53–60.
 
Reynolds, K., Novosad, B., Hoffhines, A., Gipson, J., Johnson, J., Peters, J., Gonzalez, F., Gimble, J. & Hill, M. (2002). Pretreatment with troglitazone decreases lethality during endotoxemia in mice. J. Endotoxin Res. 8, 307-314.
 
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E. & Tomlanovich, M. (2001). Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345, 1368–1377.
 
Sokkar, SM., Darwiesh, G. & Madbooly, A. (2003). Study of the pathological effect of Escherichia coli endotoxin in rams. J. Vet. Med. B Infect. Dis. Vet. Public. Health. 50, 226-230.
 
Straub, R.H., Grum, F., Strauch, U., Capellino, S., Bataille, F., Bleich, A., Falk, W., Schölmerich, J. & Obermeier, F. (2008). Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation. Gut. 57, 911-921.
 
Takala, J., Ruokonen, E., Webster, N.R., Nielsen, MS., Zandstra, D.F., Vundelinckx, G. & Hinds, CJ. (1999). Increase mortality associated with growth hormone treatment in critically ill patients. N. Engl. J. Med. 341, 785–792.
 
Tonhajzerova, I., Ondrejka, I., Chladekova, L., Farsky, I., Visnovcova, Z., Calkovska, A., Jurko, A. & Javorka, M. (2012). Heart rate time irreversibility is impaired in adolescent major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 39, 212-217.
 
Tracey, KJ. (2002).The inflammatory reflex. Nature. 420, 853-859.
 
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, PJ., Milants, I., Van Wijngaerden, E., Bobbaers, H. & Bouillon, R. (2006). Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 354, 449–461.
 
Zila, I., Mokra, D., Kopincova, J., Kolomaznik, M., Javorka, M. & Calkovska, A. (2015). Heart rate variability and inflammatory response in rats with lipopolysaccharide-induced endotoxemia. Physiol. Res. 64, S669-S676.